Gun companies made more than $1 billion from assault weapon sales over a decade, House panel says

Gun companies made more than  billion from assault weapon sales over a decade, House panel says


Fire arms are seen at the Bobâs Little Sport Gun Shop in the town of Glassboro, New Jersey, United States on May 26, 2022. 

Tayfun Coskun | Anadolu Agency | Getty Images

Major gun manufacturers have made over $1 billion in the last decade selling military-style assault weapons, according to an investigation by the House Committee on Oversight and Reform.

A memo from the panel outlines manufacturers’ revenue and marketing strategies for assault-style weapons, focusing on the the gun brands used in recent mass shootings. The release came ahead of a Wednesday hearing on the role of the firearms industry in pervasive gun violence in the United States.

Earnings from assault weapons more than doubled for brands like Smith & Wesson, Sturm Ruger and Daniel Defense between 2019 and 2021, according to House findings. Sturm Ruger CEO Christopher Killoy, and Daniel Defense CEO Marty Daniel are set to testify at Wednesday’s hearing. Smith & Wesson CEO Mark Smith was invited but won’t attend.

At the hearing, Chairwoman Rep. Carolyn B. Maloney, D-N.Y., announced that the committee will issue subpoenas to Smith & Wesson and other manufacturers.

The committee also provided estimated assault weapon revenues for these companies since 2012, the year a gunman killed 20 children and six adults at Sandy Hook Elementary School in Connecticut:

  • Smith & Wesson: $695 million
  • Sturm Ruger: $514 million
  • Daniel Defense: $528 million
  • SIG Sauer: Refused to report
  • Bushmaster: $2.9 million (2021 only)

The number of recent mass shooting deaths was also listed for each company, with assault weapons from all five brands used in at least two recent massacres. The gunman who killed 19 children and two teachers in May at Robb Elementary School in Uvalde, Texas, used a weapon made by Daniel Defense.

The brands themselves do not track deaths, injuries or crimes that involve their weapons. Sig Sauer told the committee that it does “not have the means” to track deaths. Sturm Ruger said it learns of incidents through its “customer service department,” the media or from occasional lawsuits.

The hearing comes just after California Gov. Gavin Newsom recently signed a law allowing citizens affected by gun violence to sue manufacturers.

The committee also focused on marketing tactics, including Smith & Wesson advertisements that mimic first-person shooter video games and a Sig Sauer weapon sold as an “apex predator.”

House Democrats are pushing to vote on an assault weapons ban later this week. If passed, the bill is unlikely to make it through the Senate.

Smith & Wesson, Sig Sauer and Sturm Ruger did not immediately respond to a request for comment.



Source

CDC Director Susan Monarez ousted, four other leaders quit health agency
Health

CDC Director Susan Monarez ousted, four other leaders quit health agency

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Centers for Disease […]

Read More
FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents
Health

FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents

Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them. The agency ended its […]

Read More
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Health

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Eli Lilly‘s closely watched obesity pill is inching closer […]

Read More